Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
No Thumbnail Available
Identifiers
Date
2021
Authors
Rey, Esther
Ampuero, Javier
Molina-Jiménez, Francisca
Marañón, Patricia
García-García, Yaiza
Múñoz-Hernández, Rocío
Romero-Gómez, Manuel
García-Monzón, Carmelo
Majano, Pedro
González-Rodríguez, Águeda
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Description
MeSH Terms
Antiviral Agents
Female
Hepatitis C
Humans
Insulin Receptor Substrate Proteins
Insulin Resistance
Male
Middle Aged
Sofosbuvir
Treatment Outcome
Female
Hepatitis C
Humans
Insulin Receptor Substrate Proteins
Insulin Resistance
Male
Middle Aged
Sofosbuvir
Treatment Outcome